The International Scientific Conference "CELL TECHNOLOGIES AT THE EDGE: RESEARCH & PRACTICE" (CTERP) devoted to the topic "Recent Achievements in Stem Cells Research" was held on April 6–8, 2016 in St. Petersburg.
Oral and poster presentations were attended by more than 140 students, post-graduates and researchers from leading universities and research institutions including the Danish Stem Cell Center (Danmark), Max Planck Institute of Molecular Cell Biology and Genetics and Max Planck Institute for Molecular Biomedicine(Germany), Centre for Regenerative Medicine, University of Edinburgh (UK), Cell and Gene Therapy Catapult (UK), Max-Delbruck Center for Molecular Biomedicine (Germany) and others. Institute of Cytology Russian Academy of Sciences (INC RAS) and OPTEC were the organizers of CTERP 2016.
Recent discoveries in stem cell field, most notably in pluripotent stem cell research, have opened tremendous opportunities for drug development, modeling of disease, and transplantation medicine.
The conference has to serve as a communication platform for scientists from basic and applied cell biology fields, practical doctors and biotech companies. The aim of the conference is to meet and share experience, discuss future application of stem cells, develop novel approaches of drug screening and stem cell-based practical medicine.
On the first day of the event CTERP Conference Chair Dr. Alexey Tomilin (Institute of Cytology Russian Academy of Sciences) and Co-Chair Dr. Maxim Igelnik (OPTEC) gave welcome words and opened the event. Keynote speaker Prof. Dr. Hans R. Schöler (Max Planck Institute for Molecular Biomedicine, Münster) opened the scientific part of the conference. The speech was dedicated to induction of multi- and pluripotent Stem Cells.
April 8 was the final day of the conference, which included a special session and round table meeting ‘Stem Cell: from Bench to Clinics’. The event gathered scientists and business representatives for a discussion concerning practical implementation of advanced cell technologies in Russia and abroad. The session was moderated by Prof. Marc Turner, Medical Director of Scottish National Blood Transfusion Service and Professor of Cellular Therapy, University of Edinburgh. It was opened by speech of Dr. Jacqueline Barry, Director of Regulatory Affairs for Cell and Gene Therapy Catapult, the UK’s centre for the acceleration of the translation of cell therapies towards commercialization. It was focused on biotechnology and specific generation of iPS cells under GMP conditions, as well as their use for tissue replacement therapy.
The conference was supported by RAS and Russian Foundation for Basic Research (RFBR). Grant № 16-04-20097.